Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares
Astrana Health (NASDAQ: ASTH) has announced a significant share repurchase of 300,000 shares from Allied Physicians of California (APC), a consolidated affiliate and long-standing stockholder. The transaction, completed on January 17, 2025, was executed at $35.17 per share, totaling $10.551 million.
The repurchase price was based on the closing price of Astrana's shares on the Nasdaq Stock Market on the transaction date. The company's Board of Directors and Audit Committee approved the transaction, with CEO Brandon K. Sim stating that the repurchase demonstrates management's confidence in Astrana Health's performance and commitment to strategic capital deployment practices focused on long-term growth.
Astrana Health (NASDAQ: ASTH) ha annunciato un significativo riacquisto di 300.000 azioni da Allied Physicians of California (APC), un'affiliata consolidata e azionista di lunga data. La transazione, completata il 17 gennaio 2025, è stata eseguita a $35,17 per azione, per un totale di $10,551 milioni.
Il prezzo di riacquisto è stato basato sul prezzo di chiusura delle azioni di Astrana sul mercato azionario Nasdaq nella data della transazione. Il Consiglio di Amministrazione dell'azienda e il Comitato di Audit hanno approvato l'operazione, con il CEO Brandon K. Sim che ha dichiarato che il riacquisto dimostra la fiducia della gestione nelle performance di Astrana Health e l'impegno verso pratiche strategiche di impiego di capitale focalizzate sulla crescita a lungo termine.
Astrana Health (NASDAQ: ASTH) ha anunciado una significativa recompra de 300,000 acciones de Allied Physicians of California (APC), una afiliada consolidada y accionista de larga data. La transacción, completada el 17 de enero de 2025, se ejecutó a $35.17 por acción, totalizando $10.551 millones.
El precio de recompra se basó en el precio de cierre de las acciones de Astrana en el mercado de valores Nasdaq en la fecha de la transacción. La Junta Directiva de la empresa y el Comité de Auditoría aprobaron la operación, con el CEO Brandon K. Sim afirmando que la recompra demuestra la confianza de la dirección en el rendimiento de Astrana Health y el compromiso con prácticas estratégicas de inversión de capital enfocadas en el crecimiento a largo plazo.
Astrana Health (NASDAQ: ASTH)는 캘리포니아의 Allied Physicians (APC)로부터 300,000주의 유의미한 자사주 매입을 발표했습니다. 이 거래는 2025년 1월 17일에 완료되었으며, 주당 $35.17에 실행되어 총 $10.551 백만에 달합니다.
매입 가격은 거래 날짜의 나스닥 주식 시장에서 Astrana의 주식 종가를 기준으로 하였습니다. 회사의 이사회와 감사위원회는 이 거래를 승인하였으며, CEO인 Brandon K. Sim은 자사주 매입이 Astrana Health의 성과에 대한 경영진의 신뢰와 장기적인 성장을 목표로 한 전략적 자본 배치 관행에 대한 헌신을 보여준다고 밝혔습니다.
Astrana Health (NASDAQ: ASTH) a annoncé un important rachat d'300 000 actions auprès d'Allied Physicians of California (APC), une filiale consolidée et un actionnaire de longue date. La transaction, finalisée le 17 janvier 2025, a été effectuée à un prix de $35,17 par action, totalisant $10,551 millions.
Le prix de rachat était basé sur le prix de clôture des actions d'Astrana sur le marché boursier Nasdaq à la date de la transaction. Le conseil d'administration de l'entreprise et le comité d'audit ont approuvé la transaction, le PDG Brandon K. Sim déclarant que le rachat démontre la confiance de la direction dans la performance d'Astrana Health et l'engagement envers des pratiques stratégiques de déploiement de capital axées sur la croissance à long terme.
Astrana Health (NASDAQ: ASTH) hat einen signifikanten Aktienrückkauf von 300.000 Aktien von Allied Physicians of California (APC), einer konsolidierten Tochtergesellschaft und langjährigen Aktionärin, bekannt gegeben. Die Transaktion wurde am 17. Januar 2025 abgeschlossen und zu einem Preis von $35,17 pro Aktie durchgeführt, was insgesamt $10,551 Millionen ergibt.
Der Rückkaufpreis basierte auf dem Schlusskurs von Astranas Aktien am Nasdaq-Börsenmarkt zum Zeitpunkt der Transaktion. Der Vorstand des Unternehmens und der Prüfungsausschuss genehmigten die Transaktion, wobei CEO Brandon K. Sim erklärte, dass der Rückkauf das Vertrauen des Managements in die Leistung von Astrana Health und das Engagement für strategische Kapitalverwendung mit Fokus auf langfristiges Wachstum demonstriert.
- Share repurchase of $10.551 million demonstrates strong financial position
- Company shows confidence in its performance through buyback action
- Strategic capital deployment aimed at long-term growth
- Significant cash outlay of $10.551 million reduces available capital for other investments
Insights
This
The transaction's structure is particularly noteworthy - purchasing from Allied Physicians of California, a consolidated affiliate, indicates this is more of an internal reorganization than a traditional open market buyback. This approach provides a controlled exit mechanism for the affiliate while potentially improving the company's ownership structure.
The purchase price being set at the market closing price demonstrates fair value consideration and transparency. For a company with a
The execution of this share repurchase demonstrates strong corporate governance practices. Key positive indicators include:
- Board and Audit Committee approval, showing proper oversight
- Transparent pricing mechanism using market close price
- Clear disclosure of the affiliate relationship with the selling entity
The transaction with Allied Physicians of California, while being a related-party transaction, appears to be conducted at arm's length with appropriate controls. This structured approach to share repurchases from affiliates helps maintain market confidence while providing an orderly mechanism for insider stake adjustments.
"The share repurchase is a testament to management and the Board of Directors' confidence in the performance of Astrana Health. We remain committed to our strategic capital deployment practices and continue to prioritize long-term growth, including through opportunistic share repurchases," said Brandon K. Sim, President and CEO of Astrana.
The shares were purchased from Allied Physicians of
About Astrana Health, Inc.
Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in
FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
Asher Dewhurst
investors@astranahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-announces-share-repurchase-of-300-000-shares-302356096.html
SOURCE Astrana Health, Inc.
FAQ
How many shares did Astrana Health (ASTH) repurchase on January 17, 2025?
What was the total value of ASTH's January 2025 share repurchase?
From whom did Astrana Health (ASTH) repurchase the shares?
What was the share price for ASTH's January 2025 buyback?
What is the purpose of Astrana Health's (ASTH) share repurchase program?
